Patent details

300371 Product Name: Ranolazine of een zout of solvaat daarvan

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300371
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1109558
Status:
Expired Art. 14 (a) of the EC Regulations
Application number:
300371
Procedural language:
Dutch
First Applicant Residence Country:

Marketing Authorization

Marketing Authorization Number:
EU/1/08/462/001-006
Marketing Authorization Type:
EEA
Marketing Authorization Date:
14/07/2008
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
27/11/2008
First Marketing Authorization date:
14/07/2008
Grant date:
01/10/2009
Activation date:
09/09/2019
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
27/11/2008
SPC/SPC Extension Expiration Date:
13/07/2023
Lapsed By Expiration Date:
14/07/2023
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
15/10/2018
 
 

 

Name:
Gilead Sciences Inc.
Address:
333 Lakeside Drive, 94404, Foster City, California, United States of America (US)

Historical Applicant/holder

From:
20/02/2009
To:
20/02/2009

 

Name:
CV THERAPEUTICS, INC.
Address:
3172 Porter Drive, 94304, Palo Alto, California, United States of America (US)

From:
20/02/2009
To:
15/10/2018

 

Name:
Roche Palo Alto LLC
Address:
3431 Hillview Avenue, 94304, Palo Alto, California, United States of America (US)

From:
20/02/2009
To:
20/02/2009

 

Name:
Roche Palo Alto LLC
Address:
3431 Hillview Avenue, 94304, Palo Alto, California, United States of America (US)

From:
27/11/2008
To:
20/02/2009

 

Name:
Syntex (U.S.A.) LLC
Address:
3401 Hillview Avenue, 94304, Palo Alto, California, United States of America (US)

From:
27/11/2008
To:
20/02/2009

 

Name:
CV THERAPEUTICS, INC.
Address:
3172 Porter Drive, 94304, Palo Alto, California, United States of America (US)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
27/11/2008
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
29/23
Publication date:
19/07/2023
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
37/19
Publication date:
11/09/2019
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
CO
Journal edition number:
52/18
Publication date:
19/12/2018
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
SPC
Journal edition number:
33/16
Publication date:
17/08/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

5

Bulletin Heading:
CO
Journal edition number:
2009/05
Publication date:
06/05/2009
Description:
Changes in the Netherlands Patent Register

6

Bulletin Heading:
MED
Journal edition number:
2009/05
Publication date:
06/05/2009
Description:
Other communications

7

Bulletin Heading:
SPC
Journal edition number:
2009/02
Publication date:
02/02/2009
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201801819A
Date Registered:
15/10/2018
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Gilead Sciences Inc.
Address:
333 Lakeside Drive, 94404, Foster City, California, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
53179-A053179-1
Date Registered:
20/02/2009
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
53178-A053178-1
Date Registered:
20/02/2009
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
23/08/2022
Last Annual Fee Paid Number:
24
Last Annual Fee Paid Amount:
2200 Euro
Payer:
Arnold & Siedsma BV
Filing date Document type Document Description Number of pages File Type
05/01/2016 SPC Documents Certificate SPC 1 PDF /1/7/3/0/0/0400300371/docs/300371_7_supplprotectioncertificate20210217052059762.pdf
05/01/2016 Outgoing Correspondence Decision grant 1 PDF /1/7/3/0/0/0400300371/docs/300371_11_outgoingcorrespondence20210217051827092.pdf
16/12/2015 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /1/7/3/0/0/0400300371/docs/300371_9_incomingcorrespondencepaper20210217051543130.pdf
16/12/2015 SPC Documents Annex SPC 1 PDF /1/7/3/0/0/0400300371/docs/300371_10_supplprotectioncertificate20210217051705607.pdf
01/10/2009 SPC Documents Certificate SPC 1 PDF /1/7/3/0/0/0400300371/docs/300371_3_supplprotectioncertificate20210217051157668.pdf
01/10/2009 Outgoing Correspondence Outgoing Letter 1 PDF /1/7/3/0/0/0400300371/docs/300371_14_outgoingcorrespondence20091001.pdf
17/09/2009 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /1/7/3/0/0/0400300371/docs/300371_8_incomingcorrespondencepaper20210217051042962.pdf
14/07/2009 Outgoing Correspondence Outgoing Letter 2 PDF /1/7/3/0/0/0400300371/docs/300371_1_outgoingcorrespondence20090714.pdf
13/07/2009 SPC Documents Annex SPC 2 PDF /1/7/3/0/0/0400300371/docs/300371_0_supplprotectioncertificate20210217050653025.pdf
13/07/2009 SPC Documents Annex SPC 54 PDF /1/7/3/0/0/0400300371/docs/300371_2_supplprotectioncertificate20210217050349326.pdf
17/12/2008 SPC Documents Annex SPC 4 PDF /1/7/3/0/0/0400300371/docs/300371_6_supplprotectioncertificate20210217045947194.pdf
02/12/2008 Outgoing Correspondence Outgoing Letter 1 PDF /1/7/3/0/0/0400300371/docs/300371_12_outgoingcorrespondence20081202.pdf
27/11/2008 SPC Documents Summary of the characteristics of the product 35 PDF /1/7/3/0/0/0400300371/docs/300371_5_supplprotectioncertificate20210217045732237.pdf
27/11/2008 Application Form First filed application form 2 PDF /1/7/3/0/0/0400300371/docs/300371_13_applicationform20081127.pdf
22/05/2002 SPC Documents Annex SPC 17 PDF /1/7/3/0/0/0400300371/docs/300371_4_supplprotectioncertificate20210217045302985.pdf